Harbor:Creatinine screening prior to IV contrast: Difference between revisions

 
(15 intermediate revisions by 6 users not shown)
Line 1: Line 1:
==Background==
* ED patients do NOT require creatinine measurement prior to IV contrast if the study is immediately necessary to prevent life-threatening decompensation or delay in emergent treatment (e.g., trauma patients, dissection r/o)
To expedite the appropriate use of creatinine screening in ED patients requiring IV contrast for CT or other radiographic evaluation
* [https://lacounty-my.sharepoint.com/personal/jshim_dhs_lacounty_gov/_layouts/15/onedrive.aspx?FolderCTID=0x01200042EAB0B5A27C63468CDB5666D0718199&id=%2Fpersonal%2Fjshim%5Fdhs%5Flacounty%5Fgov%2FDocuments%2FMicrosoft%20Teams%20Chat%20Files%2FUse%20of%20IV%2 DHS IV Contrast Expected Practices 10-2022]
** '''Ok to give IV contrast if GFR>30'''
** '''No need for GFR screening if age <60 with no pertinent history''' (AKI, CKD, HD with urine output, renal transplant, Metformin use)
** If the GFR<30, ER physician should state in the CT order “Clinical History” or document in the chart that IV contrast is necessary and authorized.
*** Alternately, the '''CT tech may call the physician to confirm IV contrast is necessary and authorized, and CT tech should document this communication in the chart.'''
** Screening for MRI contrast is unnecessary unless using  Eovist for liver mets study (all ED Emergent studies should use Dotarem or Gadavist)


==Guideline==
ED patients do NOT require Cr measurement prior to IV contrast if:


#  They are '''<60 years old''' AND do NOT have
==See Also==
## history of kidney failure or transplant
*[[Contrast-induced nephropathy]]
## family history of kidney failure
## diabetes, hypertension
## collagen vascular disease (eg, SLE, scleroderma, rheumatoid arthritis)
## paraproteinemia syndrome (eg, myeloma)
## recent use of nephrotoxic medication (eg, aminoglycosides)
#If the study is immediately necessary to prevent life-threatening decompensation or delay in emergent treatment


==See Also==
==References==
*[[Contrast with Renal Dysfunction]]
<ref>Tippins RB, Torres WE, Baumgartner BR, Baumgarten DA. Are screening serum creatinine levels necessary prior to outpatient CT examinations? Radiology. 2000 Aug;216(2):481-4.</ref><ref>ACR Manual on Contrast Media – Version 10, 2015. [http://www.acr.org/~/media/ACR/Documents/PDF/QualitySafety/Resources/Contrast%20Manual/2015_Contrast_Media.pdf PDF] Accessed 08/10/15</ref>:
*[[Oral Contrast for CT]]


==Source==
*American College of Radiology Manual on Contrast Administration
*Harbor-UCLA Medical Center Policy, "Emergency Department Creatinine Screening Guidelines for Radiographic Evaluations"


[[Category:Rads]]
[[Category:Radiology]]
[[Category:Nephro]]
[[Category:Renal]]
[[Category:GU]]

Latest revision as of 16:34, 22 March 2023

  • ED patients do NOT require creatinine measurement prior to IV contrast if the study is immediately necessary to prevent life-threatening decompensation or delay in emergent treatment (e.g., trauma patients, dissection r/o)
  • DHS IV Contrast Expected Practices 10-2022
    • Ok to give IV contrast if GFR>30
    • No need for GFR screening if age <60 with no pertinent history (AKI, CKD, HD with urine output, renal transplant, Metformin use)
    • If the GFR<30, ER physician should state in the CT order “Clinical History” or document in the chart that IV contrast is necessary and authorized.
      • Alternately, the CT tech may call the physician to confirm IV contrast is necessary and authorized, and CT tech should document this communication in the chart.
    • Screening for MRI contrast is unnecessary unless using Eovist for liver mets study (all ED Emergent studies should use Dotarem or Gadavist)


See Also

References

[1][2]:

  1. Tippins RB, Torres WE, Baumgartner BR, Baumgarten DA. Are screening serum creatinine levels necessary prior to outpatient CT examinations? Radiology. 2000 Aug;216(2):481-4.
  2. ACR Manual on Contrast Media – Version 10, 2015. PDF Accessed 08/10/15